Showing results (131-140 of 181) with videos related to
Sort By:
Pageof 19
Kardiologia Polska|October 13, 2021
Pulmonary embolism response team: A multidisciplinary approach to pulmonary embolism treatment. Polish PERT Initiative ReportAleksander Araszkiewicz, Marcin Kurzyna, Grzegorz Kopeć, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 20, 2023
Acute pulmonary embolism with coexisting right heart thrombi in transit-surgical treatment of 20 consecutive patientsDariusz Zieliński, Marcin Zygier, Wojciech Dyk, et al.Cancers|April 27, 2024
Safety and Outcomes of Inferior Vena Cava Filter Placement in Oncology Patients: A Single-Centre ExperiencePaweł Kurzyna, Marta Banaszkiewicz, Michał Florczyk, et al.JACC. Cardiovascular Imaging|November 21, 2021
The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial HypertensionAnton Vonk Noordegraaf, Richard Channick, Emmanuelle Cottreel, et al.ERJ Open Research|February 13, 2024
Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIRDavid G Kiely, Richard Channick, Dayana Flores, et al.Journal of the American College of Cardiology|May 3, 2002
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trialNazzareno Galiè, Marc Humbert, Jean-Luc Vachiéry, et al.European Heart Journal|September 2, 2008
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Adam Torbicki, Arnaud Perrier, Stavros Konstantinides, et al.Heart (British Cardiac Society)|December 25, 2016
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertensionNick H Kim, Andrea M D'Armini, Friedrich Grimminger, et al.Advances in Therapy|July 12, 2022
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label ExtensionRogério Souza, Marion Delcroix, Nazzareno Galié, et al.Journal of the American College of Cardiology|December 21, 2013
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiologyAnton Vonk-Noordegraaf, François Haddad, Kelly M Chin, et al.Pageof 19